Services
Stock Market Masterclass
Option Trading with CA Abhay
FNO Stocks with CA Abhay
Equity Trading with CA Abhay
Equity Investment with CA Abhay
Identical Brains Studios IPO Allotment – 3 Ways To Check Allotment Status
Team Finance Saathi
24/Dec/2024
What's covered under the Article:
- Detailed review of Identical Brains Studios IPO with pricing, subscription details, and GMP.
- Overview of the company's financial performance and valuation.
- Step-by-step guide on how to check the IPO allotment status.
Identical Brains Studios is a leading provider of computer-generated visual effects (VFX) services in India, offering a comprehensive range of VFX services for films, web series, TV shows, documentaries, and commercials. With a strong presence in the Indian film industry, including collaborations with major Bollywood studios, the company transforms creative ideas into visually captivating realities, employing a team of highly skilled professionals and proprietary workflow technologies.
The Identical Brains Studios IPO is a Book Built Issue amounting to ₹19.95 Crores, comprising a fresh issue of 36.94 Lakh shares. The subscription period for the IPO began on December 18, 2024 and closed on December 20, 2024. The allotment date is set for December 23, 2024, and the shares are expected to be listed on the NSE SME platform on December 26, 2024.
The price band for the IPO is set at ₹51 to ₹54 per equity share, and the market capitalization at the upper price of ₹54 per share will be ₹75.74 Crores. The lot size is 2,000 shares, requiring retail investors to invest a minimum of ₹1,08,000. High-Net-Worth Individuals (HNIs) are required to invest a minimum of 2 lots (4,000 shares), totaling ₹2,16,000.
Identical Brains Studios IPO GMP Today
The Grey Market Premium (GMP) for the Identical Brains Studios IPO stands at ₹28, signaling a potential listing gain of 51.85%. The listing price is anticipated to be around ₹82, which presents an attractive return based on the GMP. However, it's important to note that GMP is speculative and unofficial, so investors should be cautious when considering it for trading purposes.
Identical Brains Studios IPO Subscription Status
As of December 20, 2024, the Identical Brains Studios IPO was subscribed 506.09 times, indicating substantial demand from investors. This high subscription rate suggests strong market confidence in the company's potential and its future growth prospects within the VFX industry.
Identical Brains Studios IPO Anchor Investors Report
Identical Brains Studios raised ₹5.65 Crores from Anchor Investors at the price of ₹54 per share, allocating 10,48,000 equity shares. This is a positive sign, as it reflects institutional interest in the company's future prospects and the IPO's pricing.
Identical Brains Studios IPO Allotment Date
The IPO allotment date for Identical Brains Studios is set for December 23, 2024. Investors can check their allotment status by visiting the registrar's website. Here's how to check:
- Go to the IPO allotment status page.
- Select Identical Brains Studios IPO from the dropdown.
- Enter your application number, PAN, or DP Client ID.
- Submit the details to view your allotment status.
Identical Brains Studios IPO Review
Identical Brains Studios has shown impressive growth, particularly in the VFX industry, with revenues increasing from ₹390.75 Lakh in FY2022 to ₹1,139.49 Lakh in FY2024. The company's EBITDA for FY2024 was ₹433.14 Lakh, with a profit after tax (PAT) of ₹240.54 Lakh for the same period.
The company's financial performance is robust, with a pre-issue EPS of ₹5.18 and post-issue EPS of ₹3.81. The pre-issue P/E ratio is 10.42x, while the post-issue P/E ratio stands at 14.17x, compared to the industry P/E ratio of 15x, indicating that the IPO is fairly priced. The return on capital employed (ROCE) for FY24 is an impressive 103.52%, and the return on equity (RoE) is 71.66%, signaling strong profitability.
Given the strong financials, GMP performance, and substantial subscription demand, Identical Brains Studios IPO presents an attractive opportunity for listing gains. However, given the higher post-issue P/E ratio, only risk-seeking investors should consider investing for listing gains.
For long-term investments, the company’s growth potential in the VFX market could be appealing, but investors should assess their risk tolerance before investing.